Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
43598-2 Indicans PrThr Urine 24H Ord     ACTIVE Indicans [Presence] in 24 hour Urine   MIN DefinitionDescription                   CHEM   43598-2         Both       0 Indicans 24h Ur Ql       N   1 day; 24 hours; 24HR; Chemistry; Indoxyl sulfate; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43599-0 HIV 1 Ab ACnc Ser Pt Qn IF   ACTIVE HIV 1 Ab [Units/volume] in Serum by Immunofluorescence   MIN DefinitionDescription                   MICRO   43599-0   IF     Both       0 HIV1 Ab Ser IF-aCnc       N   ABS; Aby; ACIF; AIDS; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Arbitrary concentration; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; HIV type 1; HIV type I; HIV1; Human immunodeficiency virus; i; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Time Resolved Fluorescence; TRF 2.69 2.17               [arb'U]/mL       0
436-6 Rolitetracycline Susc Isolate Pt OrdQn MIC   ACTIVE Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   436-6   MIC     Observation       0 Rolitetracycline Islt MIC           ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; PMT; Point in time; Pyrrolidinomethyltetracycline; Random; Reverin; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Transcycline 2.19 1                       0
4360-4 Normetanephrine Mass Dose Pt Qn     ACTIVE Normetanephrine [Mass] of Dose   MIN DefinitionDescription                   DRUGDOSE   4360-4         Observation       0 Normetanephrine Dose       Y   Dose med or substance; DRUG DOSES; Normeta; Normetaneph; Normetanephrn; Point in time; QNT; Quan; Quant; Quantitative; Random 2.69 1               mg       0
43600-6 Ganglioside GD1b Ab.IgM PrThr Ser Pt Ord     ACTIVE Ganglioside GD1b IgM Ab [Presence] in Serum   MIN DefinitionDescription                   SERO   43600-6         Both       0 GD1b Gangl IgM Ser Ql       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; Immune globulin M; Immunoglobulin M; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43601-4 Ganglioside GD1b Ab.IgG PrThr Ser Pt Ord     ACTIVE Ganglioside GD1b IgG Ab [Presence] in Serum   MIN DefinitionDescription                   SERO   43601-4         Both       0 GD1b Gangl IgG Ser Ql       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Disialolganglioside; Disialylganglioside; GD1b; GD1b Gangl; Immune globulin G; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43602-2 Echinococcus granulosus Ab ACnc Ser Pt Qn IA   ACTIVE Echinococcus granulosus Ab [Units/volume] in Serum by Immunoassay   MIN DefinitionDescription                   MICRO   43602-2   IA     Both       0 E granulosus Ab Ser IA-aCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; E granulosus; Echinococcosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS 2.69 2.17               [arb'U]/mL     The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. 0
43603-0 Androstenedione^1st specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   43603-0         Observation       0 Androst sp1 p chal SerPl-mCnc       N   Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; First; gamma-4-Androstenedione; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR 2.73 2.17               ng/dL       0
43604-8 Aldosterone^1st specimen post XXX challenge MCnc Ser/Plas Pt Qn     ACTIVE Aldosterone [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge   MIN DefinitionDescription     ng/dL             CHAL   43604-8         Observation       0 Aldost sp1 p chal SerPl-mCnc       N   Acute specimen; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; First; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; Pre immunization; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp1; sp1 p chal; Spec; SR 2.73 2.17               ng/dL       0
43605-5 Albumin MCnc Urine 4H Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin [Mass/volume] in 4 hour Urine   MIN DefinitionDescription     mg/dL             CHEM   43605-5   Detection limit <= 20 mg/L     Both       0 Microalbumin 4h Ur-mCnc       N   240 minutes; 4 hours; 4.0Hr; 4HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn 2.34 2.17               mg/dL       0
43606-3 Albumin MRat Urine 4H Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin [Mass/time] in 4 hour Urine   MIN DefinitionDescription     ug/min             CHEM   43606-3   Detection limit <= 20 mg/L     Both       0 Microalbumin 4h Ur-mRate       N   240 minutes; 4 hours; 4.0Hr; 4HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn 2.3 2.17               ug/min       0
43607-1 Albumin MRat Urine 12H Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin [Mass/time] in 12 hour Urine   MIN DefinitionDescription     ug/min             CHEM   43607-1   Detection limit <= 20 mg/L     Both       0 Microalbumin 12h Ur-mRate       N   12 hours; 12HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn 2.3 2.17               ug/min       0
43608-9 Adrenal cortex Ab PrThr Ser Pt Ord     ACTIVE Adrenal cortex Ab [Presence] in Serum   MIN DefinitionDescription                   SERO   43608-9         Both       0 Adrenal cortex Ab Ser Ql       N   ABS; Aby; ACA; Adrnl; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43609-7 Adipate PrThr Urine 24H Ord     ACTIVE Adipate [Presence] in 24 hour Urine   MIN DefinitionDescription                   CHEM   43609-7         Both       0 Adipate 24h Ur Ql       N   1 day; 24 hours; 24HR; Adipic acid; Chemistry; Hexanedioate; Hexanedioic acid; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
4361-2 Nortriptyline Mass Dose Pt Qn     ACTIVE Nortriptyline [Mass] of Dose   MIN DefinitionDescription                   DRUGDOSE   4361-2         Observation       0 Nortrip Dose       Y   Amitriptyline metabolite; Aventyl; Dose med or substance; DRUG DOSES; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Point in time; QNT; Quan; Quant; Quantitative; Random 2.69 1               mg       0
43610-5 Adenovirus Ag PrThr Nph Pt Ord IF   ACTIVE Adenovirus Ag [Presence] in Nasopharynx by Immunofluorescence   MIN DefinitionDescription                   MICRO   43610-5   IF     Both       0 HAdV Ag Nph Ql IF       N   ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; TRF 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43611-3 Adenovirus Ag PrThr Bronchial Pt Ord IF   ACTIVE Adenovirus Ag [Presence] in Bronchial specimen by Immunofluorescence   MIN DefinitionDescription                   MICRO   43611-3   IF     Both       0 HAdV Ag Bronch Ql IF       N   ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; Bro; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43612-1 Adenovirus Ag PrThr Nose Pt Ord IF   ACTIVE Adenovirus Ag [Presence] in Nose by Immunofluorescence   MIN DefinitionDescription                   MICRO   43612-1   IF     Both       0 HAdV Ag Nose Ql IF       N   ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell; Time Resolved Fluorescence; TRF 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43613-9 Adenovirus Ag PrThr Trac Pt Ord IF   ACTIVE Adenovirus Ag [Presence] in Trachea by Immunofluorescence   MIN DefinitionDescription                   MICRO   43613-9   IF     Both       0 HAdV Ag Trachea Ql IF       N   ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Trachea; TRF 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43614-7 Adenovirus Ag PrThr Nose Pt Ord     ACTIVE Adenovirus Ag [Presence] in Nose   MIN DefinitionDescription                   MICRO   43614-7         Both       0 HAdV Ag Nose Ql       N   Adeno virus; Antigen; Antigens; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasal; Nos; Nose (nasal passage); Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Smell 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43615-4 Adenovirus Ag PrThr Genital Pt Ord     ACTIVE Adenovirus Ag [Presence] in Genital specimen   MIN DefinitionDescription                   MICRO   43615-4         Both       0 HAdV Ag Genital Ql       N   Adeno virus; Antigen; Antigens; Gen; Genital tract; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Urogenit; Urogenital 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43616-2 Adenovirus Ab PrThr Ser Pt Ord     ACTIVE Adenovirus Ab [Presence] in Serum   MIN DefinitionDescription                   MICRO   43616-2         Both       0 HAdV Ab Ser Ql       N   ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43617-0 Adenovirus Ab PrThr CSF Pt Ord     ACTIVE Adenovirus Ab [Presence] in Cerebral spinal fluid   MIN DefinitionDescription                   MICRO   43617-0         Both       0 HAdV Ab CSF Ql       N   ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43618-8 Adenovirus Ab PrThr Ser Pt Ord Comp fix   ACTIVE Adenovirus Ab [Presence] in Serum by Complement fixation   MIN DefinitionDescription                   MICRO   43618-8   Comp fix     Both       0 HAdV Ab Ser Ql CF       N   ABS; Aby; Adeno virus; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; HAdV; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.73 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
43619-6 Actinomyces sp Ab PrThr Ser Pt Ord     ACTIVE Actinomyces sp Ab [Presence] in Serum   MIN DefinitionDescription                   MICRO   43619-6         Both       0 Actinomyces Ab Ser Ql       N   ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR 2.56 2.17                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found